January 28, 2010 / 5:33 AM / 9 years ago

TABLE-Kainos <4556.Q>-9-mth parent results

   Jan 28 (Reuters) -
                KAINOS LABORATORIES INC
                PARENT-ONLY FINANCIAL HIGHLIGHTS
 (in billions of yen unless specified)
             9 months ended  9 months ended    Year to   
               Dec 31, 2009    Dec 31, 2008    Mar 31, 2010
               LATEST          YEAR-AGO        LATEST    
               RESULTS         RESULTS         FORECAST  
 Sales               3.12            2.63            4.10   
                (+18.8 pct)                              
 Operating       prft 176 mln     loss 15 mln    prft 190 mln
 Recurring       prft 159 mln     loss 31 mln    prft 166 mln
 Net                   79 mln         144 mln          85 mln
                (-45.2 pct)                              
 EPS                   Y17.80          Y32.46          Y19.08
 NOTE - Kainos Laboratories Inc is a manufacturer of clinical reagents for biochemical and immune serum studies.
 If there is no Q1 or Q3 dividend, Q2 will in most cases
correspond to the first-half dividend and Q4 to the second-half
dividend announced before a new corporate law in 2006 allowed
companies to pay and report dividends on a quarterly basis.
 For latest earnings estimates made by Toyo Keizai, please
double click on 4556.TK1.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below